The CMS has moved quickly to replace two recently departed senior executives. The experience levels of the announced replacements should allay concerns that the mini-exodus, which some saw as fallout from launch issues with HealthCare.gov, would hurt agency operations, former CMS insiders agreed.
The CMS has moved quickly to replace two recently departed senior executives. The experience levels of the announced replacements should allay concerns that the mini-exodus, which some saw as fallout from launch issues with HealthCare.gov, would hurt agency operations, former CMS insiders agreed.
In a span of just weeks, starting in mid-November and ending in late December, both the CMS' Chief Information Officer Tony Trenkle and Chief Operating Officer Michelle Snyder left the agency, taking with them decades of institutional knowledge. Their departure capped off a year that also saw the CMS' Chief Actuary Richard Foster leave the agency after 18 years of service in January 2013.
But on Tuesday, the CMS announced it had promoted Tim Love to COO and Dave Nelson to CIO. Love has been with the CMS for the past 22 years, and was most recently acting deputy COO. Nelson has been with the agency 10 years and was most recently acting CIO. In June, the CMS tapped Paul Spitalnic as a replacement for Foster. He has been at the agency since 2003.
Read the full story here: http://bit.ly/1asbanr
Source: Modern Healthcare
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More